Company Announcements:
(reported by the Company)
No items found
Elevator Pitch:

Orthocell is an Australian regenerative medicine company dedicated to improving the lives of people suffering from musculoskeletal injuries.

Category: Health & biotech
URL: http://www.orthocell.com.au/
Operational Status: Active
ASX Listing Code (if applicable): OCC
Year of Commencement:
State: Western Australia
Overseas Operations: No
Key Personnel:
Awards won:
Current Period Rank:

Annual Rank (top 100 ranked companies only): 80

WA Annual Rank 2016: 43


    January, 2018

    Secured Canadian patent

    Secured European patent for unique tissue repair technology

    Appointed Surgical Specialties as its exclusive distributor in Australia and New Zealand

    September, 2017

    Treated its first patient in a randomised controlled clinical trial of Ortho-ATI versus corticosteroid injection

    Granted a further Australian patent for its CelGro collagen medical device platform for soft tissue regeneration and repair applications

    June, 2017

    Ortho-ACI included on the Australian Register of Therapeutic Goods

    February, 2017

    Granted European patent for tissue repair technology

    January, 2017

    Announces collaboration with Johnson & Johnson

    December, 2016

    $4m raised through a placement of 10m shares

    November, 2016

    Finalist at WA Industry and Export Awards

    October, 2016

    Won ethics approval for a human study evaluating its CelGro collagen soft tissue repair device


Company News:

NOTE: Company News, Milestones and Funding are as collected by Techboard as part of our Monthly Startup Ranking

Amount Seeking:
Type of capital raise:
Pre-money valuation:
ESIC Status:
ESIC Upload:
Future Intentions:
Investment Video:
Investment Pitchdeck:
Investment URL:
Investment Phone:
Investment Email:

Leave a Reply